Difference between revisions of "Imatinib (Gleevec)"
Jump to navigation
Jump to search
(Created page with "==General information== Class/mechanism: <ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/gleevec_tabs.pdf Imatinib (Gleevec) package insert]</ref><ref>[http:...") |
|||
| Line 1: | Line 1: | ||
| + | Also known as imatinib mesylate. | ||
==General information== | ==General information== | ||
Class/mechanism: <ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/gleevec_tabs.pdf Imatinib (Gleevec) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/imatinib.pdf Imatinib (Gleevec) package insert (locally hosted backup)]</ref> | Class/mechanism: <ref name="insert">[http://www.pharma.us.novartis.com/product/pi/pdf/gleevec_tabs.pdf Imatinib (Gleevec) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/imatinib.pdf Imatinib (Gleevec) package insert (locally hosted backup)]</ref> | ||
Revision as of 01:53, 24 December 2011
Also known as imatinib mesylate.
General information
Class/mechanism: [1][2]
Route: TBD
Extravasation: TBD
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Patient drug information
- Imatinib (Gleevec) patient drug information (Chemocare)[3]
- Imatinib (Gleevec) patient drug information (UpToDate)[4]